Springer launches American Joint Committee on Cancer e-Staging Tool

NewsGuard 100/100 Score

Springer is launching the AJCC e-Staging Tool, a web-based application which will improve the way cancer is staged.  Designed to meet the needs of the entire multidisciplinary team in any facility that deals with cancer, the AJCC e-Staging Tool makes the process quicker, more efficient and more accurate.  The content draws from the highly successful AJCC Cancer Staging Manual, 7th edition, published by Springer in 2010.

The American Joint Committee on Cancer (AJCC) Cancer Staging System is the preeminent paradigm used throughout the world to diagnose cancer and determine the extent of disease.  The AJCC Cancer Staging Manual brings together the relevant, evidence-based criteria for the staging of cancer for 57 anatomic primary sites.  Solving the problems that paper formats sometimes present, the AJCC e-Staging Tool's simple workflow interface facilitates physician and cancer registrar communication at any point in the patient work-up.

Users supply the appropriate parameters of tumor, node and metastasis along with relevant predictive or prognostic information to derive the patient's stage.  The forms may be shared among members of the patient management team and saved in tandem with electronic and print patient records.

A subscription to the AJCC e-Staging Tool includes access to a comprehensive and interactive guide to the general rules of cancer staging and specific classifications for T, N, and M.  The tool provides an easy-to-use staging calculator and electronic staging form for inclusion in patient clinical records and for retrospective staging of patients for public health reporting purposes.

http://www.ajcce-staging.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Gut microbiome study challenges established cancer biomarkers, identifies new bacterial links to colorectal cancer